MUFG Americas’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
CI
APM
MUFG Americas's XBI Position: Q3 2022 in Review
MUFG Americas sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2022, closing a stake of 200 shares — an estimated $15K sold.
MUFG Americas first reported a position in XBI in Q4 2021 and held it in 3 quarters. The position peaked at $31K in Q1 2022. 704 funds tracked by Wall St. Rank hold XBI as of Q3 2022.
- MUFG Americas reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2022 after selling out during the quarter.
- MUFG Americas sold 200 State Street SPDR S&P Biotech ETF shares in Q3 2022, an estimated $15K.
- MUFG Americas first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and held it in 3 quarters.
- MUFG Americas's State Street SPDR S&P Biotech ETF position peaked at $31K in Q1 2022.
- 704 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2022.
Based on MUFG Americas's 13F filing for Q3 2022, filed 1 Nov 2022.